Raising alarms, study sees trials migrating abroad

John Carroll at FierceBiotech.com reports that the U.S. drug industry has shifted most of its clinical trials to overseas sites in a trend that experts warn raises serious ethical concerns. According to a study in the New England Journal of Medicine, 13,521 of 24,206 trial sites being sponsored by the top 20 U.S. drug companies in late 2007 were taking place beyond our borders, where data can be harvested cheaper and faster than the data gathered inside the U.S. And the study adds that the number of countries hosting trials has doubled in 10 years. Most of the countries hosting clinical trials may be using individuals who could never afford the medications and approval for these trials has been less than half. What are your thoughts?

Share this article with your social network, just click below to share now!

Share |